Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 7, 2017; 23(1): 76-86
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.76
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.76
Figure 4 Changes in markers of apoptosis and inflammation in the dextran sulfate sodium, UCP2 and miR-133a groups.
A: Changes in apoptosis in the different groups, as shown by dTUNEL staining (brown colour in the cell indicates apoptosis); B: Changes in the levels of IL-6, MCP1, TNF-α and IL-1β in the different groups. aP < 0.05, bP < 0.01 vs control; cP < 0.05, dP < 0.01 vs DSS. DSS: Dextran sulfate sodium.
- Citation: Jin X, Chen D, Zheng RH, Zhang H, Chen YP, Xiang Z. miRNA-133a-UCP2 pathway regulates inflammatory bowel disease progress by influencing inflammation, oxidative stress and energy metabolism. World J Gastroenterol 2017; 23(1): 76-86
- URL: https://www.wjgnet.com/1007-9327/full/v23/i1/76.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i1.76